tiprankstipranks
Aoyuan Healthy Life Group Co. Ltd. (HK:3662)
:3662
Hong Kong Market

Aoyuan Healthy Life Group Co. Ltd. (3662) AI Stock Analysis

1 Followers

Top Page

HK:3662

Aoyuan Healthy Life Group Co. Ltd.

(3662)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 5.2)
Rating:63Neutral
Price Target:
HK$0.44
▼(-0.68% Downside)
Action:ReiteratedDate:10/23/25
The overall stock score of 63 reflects a mixed outlook for Aoyuan Healthy Life Group Co. Ltd. The most significant factor is the company's financial performance, which shows a strong balance sheet but declining revenue and cash flow challenges. Technical analysis indicates bearish momentum, which is a concern. However, the stock's valuation is attractive with a low P/E ratio and high dividend yield, providing some upside potential.
Positive Factors
Strong balance sheet, low leverage
Aoyuan’s very low leverage and >50% equity ratio provide durable financial flexibility. This reduces refinancing and solvency risk, supports investment or M&A, and gives buffer to withstand cyclical shocks—strengthening the company’s long-term resilience and optionality.
Negative Factors
Sustained revenue decline
Consistent multi-year revenue contraction undermines scale and fixed-cost absorption, reducing operating leverage. Over months this can impair reinvestment capacity, shrink addressable market share, and pressure long-term growth prospects if not reversed by strategic initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet, low leverage
Aoyuan’s very low leverage and >50% equity ratio provide durable financial flexibility. This reduces refinancing and solvency risk, supports investment or M&A, and gives buffer to withstand cyclical shocks—strengthening the company’s long-term resilience and optionality.
Read all positive factors

Aoyuan Healthy Life Group Co. Ltd. (3662) vs. iShares MSCI Hong Kong ETF (EWH)

Aoyuan Healthy Life Group Co. Ltd. Business Overview & Revenue Model

Company Description
Aoyuan Healthy Life Group Company Limited, through its subsidiaries, provides property management and commercial operational services in the People's Republic of China. The company offers property management services for high-end residence communi...
How the Company Makes Money
Aoyuan Healthy Life Group generates revenue through multiple key streams, primarily from its health management services, property management fees, and sales of wellness products. The company's health management services provide preventive healthca...

Aoyuan Healthy Life Group Co. Ltd. Financial Statement Overview

Summary
Aoyuan Healthy Life Group Co. Ltd. shows a mixed financial performance. The income statement reveals declining revenue and profitability margins, indicating challenges in maintaining growth and operational efficiency. The balance sheet is robust with low leverage and strong equity, suggesting resilience. However, cash flow analysis reveals potential concerns with negative operating cash flow, which may hinder future growth and investment capabilities.
Income Statement
65
Positive
Balance Sheet
75
Positive
Cash Flow
55
Neutral
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.27B1.36B1.56B1.63B1.94B1.41B
Gross Profit334.58M385.04M399.62M397.21M469.57M488.68M
EBITDA116.89M160.95M198.54M245.27M-108.96M368.71M
Net Income39.56M96.22M157.14M160.41M-190.94M251.11M
Balance Sheet
Total Assets2.29B2.36B2.28B2.22B2.29B2.55B
Cash, Cash Equivalents and Short-Term Investments958.01M1.05B984.50M857.81M1.21B1.51B
Total Debt103.59M81.69M114.94M158.29M412.59M518.52M
Total Liabilities1.04B1.11B1.13B1.23B1.50B1.49B
Stockholders Equity1.21B1.20B1.10B931.48M747.32M1.04B
Cash Flow
Free Cash Flow75.76M107.61M93.52M-108.95M-98.54M505.54M
Operating Cash Flow107.38M140.33M106.01M-105.68M-86.34M531.10M
Investing Cash Flow-42.51M-30.53M67.93M-50.65M31.09M-225.22M
Financing Cash Flow-32.61M-51.28M-48.34M-272.10M-245.32M376.79M

Aoyuan Healthy Life Group Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.44
Price Trends
50DMA
0.40
Negative
100DMA
0.42
Negative
200DMA
0.47
Negative
Market Momentum
MACD
-0.02
Positive
RSI
19.78
Positive
STOCH
19.44
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3662, the sentiment is Negative. The current price of 0.44 is above the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.40, and below the 200-day MA of 0.47, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 19.78 is Positive, neither overbought nor oversold. The STOCH value of 19.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3662.

Aoyuan Healthy Life Group Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$537.09M1.7811.34%5.01%-31.83%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
63
Neutral
HK$225.14M3.653.28%6.60%-14.43%-77.55%
56
Neutral
HK$254.68M3.996.98%3.90%-3.62%26.66%
51
Neutral
HK$183.58M4.01-3.45%15.45%6.30%-128.34%
43
Neutral
HK$203.52M13.702.10%0.88%-25.81%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3662
Aoyuan Healthy Life Group Co. Ltd.
0.31
-0.15
-33.19%
HK:9608
Sundy Service Group Co. Ltd
0.05
-0.04
-43.62%
HK:1922
Yincheng Life Service Co., Ltd.
1.36
0.00
0.00%
HK:2107
First Service Holding Limited
0.15
-0.13
-47.00%
HK:2165
Ling Yue Services Group Limited
1.88
0.67
55.37%
HK:2376
Lushang Life Services Co., Ltd. Class H
1.91
0.49
34.51%

Aoyuan Healthy Life Group Co. Ltd. Corporate Events

Aoyuan Healthy Life Unit Signs 10-Year Lease for Guangzhou Retail Space
Jan 23, 2026
Aoyuan Healthy Life Group’s wholly owned subsidiary Guangzhou Panyu Yuexi has signed a 10-year lease for all supermarket, catering and retail shop units on Basement Level 1 of Panyu Aoyuan Plaza in Guangzhou, with a gross floor area of about...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025